|
|
|
Insider
Information: |
Mendel Scott |
Relationship: |
|
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
170,343 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$279,422 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
170,343 |
|
|
Total
Value |
$279,422 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
10
|
Stock
price went up :
|
2
|
10
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
2.0
|
10.0
|
Percentage
Gain/Loss : |
13.5%
|
1,229.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Genmark Diagnostics, Inc. |
GNMK |
President & CEO, Direc... |
2021-04-22 |
0 |
2021-04-22 |
0 |
Premium* |
|
Akoya Biosciences, Inc. |
AKYA |
Director |
2023-06-12 |
28,500 |
2021-11-19 |
0 |
Premium* |
|
Highcape Capital Acquisition Corp. |
QSI |
|
2023-05-12 |
141,843 |
2023-05-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
73 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
|
2014-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
53,764 |
53,764 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
|
2015-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
11,822 |
65,586 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
|
2016-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
87,197 |
139,640 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
|
2017-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
162,761 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
|
2018-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
117,000 |
246,161 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Chief Operating Officer |
|
2019-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
127,500 |
363,277 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Interim President & CEO |
|
2020-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
225,000 |
551,172 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
President & CEO |
|
2020-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
497,328 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
President & CEO |
|
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
80,070 |
554,146 |
0 |
- |
|
QSI |
Highcape Capital Acquisit... |
|
|
2023-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
141,843 |
141,843 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
President & CEO |
|
2020-08-12 |
4 |
AS |
$15.08 |
$754,000 |
I/I |
(50,000) |
131,690 |
0 |
% |
|
GNMK |
Genmark Diagnostics, Inc. |
President & CEO |
|
2020-08-26 |
4 |
AS |
$15.02 |
$751,000 |
I/I |
(50,000) |
81,690 |
0 |
% |
|
GNMK |
Genmark Diagnostics, Inc. |
President & CEO |
|
2021-01-19 |
4 |
AS |
$14.54 |
$727,000 |
I/I |
(50,000) |
115,491 |
0 |
% |
|
GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
|
2015-08-24 |
4 |
B |
$9.10 |
$91,000 |
I/I |
10,000 |
23,441 |
1.99 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
|
2015-10-30 |
4 |
B |
$6.47 |
$64,700 |
I/I |
10,000 |
33,441 |
1.99 |
- |
|
AKYA |
Akoya Biosciences, Inc. |
Director |
|
2021-11-19 |
4 |
B |
$13.16 |
$111,860 |
D/D |
8,500 |
8,500 |
2.39 |
% |
|
AKYA |
Akoya Biosciences, Inc. |
Director |
|
2023-06-12 |
4 |
B |
$5.00 |
$100,000 |
D/D |
20,000 |
28,500 |
2.39 |
% |
|
GNMK |
Genmark Diagnostics, Inc. |
President & CEO |
|
2021-02-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,952) |
474,076 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
President & CEO |
|
2021-02-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,860) |
552,286 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
President & CEO |
|
2021-02-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,254) |
549,032 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
President & CEO |
|
2021-02-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(41,834) |
507,198 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
President & CEO |
|
2021-04-22 |
4 |
D |
$24.05 |
$12,198,112 |
D/D |
(507,198) |
0 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
President & CEO |
|
2021-04-22 |
4 |
D |
$24.05 |
$2,777,559 |
I/I |
(115,491) |
0 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
|
2016-01-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
298 |
52,443 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
|
2017-01-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,564 |
160,933 |
0 |
- |
|
73 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|